Phase 2 Study of 500 mg BID NTZ on Top of Standard of Care in Patients With Acute Decompensation of Liver Cirrhosis at High Risk of Progression to Acute-on-Chronic Liver Failure or Established Acute-on-Chronic Liver Failure

Clinical trial NCT07694297 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07694297
Sponsor: Genfit
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Decompensation of Liver Cirrhosis Established Acute-on-Chronic Liver Failure

Start date: 2026-10-01
Primary completion: 2027-08-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.